ETF · ALPS
0H6M ALPS Medical Breakthroughs ETF
ISIN US00162Q5936London Stock Exchange: 0H6MSS&C Technologies Holdings, Inc.
- Healthcare
- ETF
- Distributing
Latest close
LSE$57.34
on
Close unchanged since 12/11/2026 — the same price has been reported every trading day since, so this line may not have traded.
- Ongoing charge
- 0.50% a year
- Fund size
- £135m
As of , at least 15 min delayed
At a glance
As of 20/11/2026, 0H6M (ALPS Medical Breakthroughs ETF, ISIN US00162Q5936) closed at $57.34 on the London Stock Exchange. Its ongoing charge is 0.50% a year (about £50 on £10,000). Over the five years to 20/11/2026 its total return was +28.5%, or +0.8% after UK CPIH inflation.
Past returns
- 1 year to 20/11/2026
- +29.0%
- +24.4% after inflation (UK CPIH)
- 3 years to 20/11/2026
- +137.6%
- +114.0% after inflation (UK CPIH)
- 5 years to 20/11/2026
- +28.5%
- +0.8% after inflation (UK CPIH)
£1,000 put in five years ago would have been worth about £1,285 on 20/11/2026 — about £1,008 in today’s spending power, once price rises are taken out. Past performance is not a guide to future returns.
Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.
How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH
Risk: volatility and largest fall
Volatility (annualised)
40.2%over 1 year
Annualised from weekly returns. Higher means bumpier.
- Largest fall, 1 year
- −23.2%
How we work it out:Risk figuresFallsVolatilityLargest fall
Charges compared with similar funds
- Ongoing charge
- 0.50%
- a year
- On £10,000
- £50
- a year, roughly
- Over five years
- £248
- of £10,000, before growth
- 24 charge less
- 1 the same
- 4 charge more
Ongoing charge of ALPS Medical Breakthroughs ETF 0.50% a year. Compared on 21/11/2026, 4 of the 29 other healthcare funds charge more, 1 the same and 24 less (share classes counted once).
As of
A lower charge is not a promise of a higher return: what the fund holds matters more.
As of
Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up
In plain English
ALPS Medical Breakthroughs ETF is an exchange-traded fund (ETF) from ALPS, launched in 2014.
It tracks the S-Network Medical Breakthroughs Index.
You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.
Its ongoing charge is 0.5% a year — about £50 a year on every £10,000 invested, taken from the fund's value rather than billed to you.
Income from its investments is paid out to holders as cash.
Healthcare: Pharmaceutical, biotech and medical-equipment companies.
Key facts
- Ticker
- 0H6M
- ISIN
- US00162Q5936
- Provider
- ALPS
- Tracks
- S-Network Medical Breakthroughs Index
- Structure
- ETF
- An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
- Income
- Distributing, paid once a year
- Income is paid out to holders as cash.
- Ongoing charge
- 0.50% a year · about £50 on £10,000
- Fund size
- £135m
- Launched
- Domicile
- United States
- Currency hedged
- No
- Price currency
- USD
- Category
- Healthcare
Price chart
Over the last year, the closing price went from $46.63 on 21/11/2025 to $57.34 on 20/11/2026 (+23.0%). The lowest close shown was $46.63 on 21/11/2025 and the highest $68.22 on 21/08/2026.
One close a week. Before 18/09/2026 the closes are from the weekly price history for this listing; from then on, the closing prices we have recorded. Price only — income paid out is not included, so the line can end below the total return above.
As of , at least 15 min delayed
Five years of prices, and after inflation
55 weekly closes, from 10/12/2021 to 20/11/2026. The same history in November 2026 pounds, adjusted with CPIH inflation.
Create a free account to see the 5-year price chart and the after-inflation chart
Sign-up takes an email address. There is no card to enter and nothing to pay.
How we work it out:Prices and returnsNAV and price
Risk and return in depth
Sharpe, Sortino and Calmar ratios
Sharpe, Sortino and Calmar ratios over 1 year, from weekly returns in pounds.
With a free account
Create a free account to see the risk ratios
Sign-up takes an email address. There is no card to enter and nothing to pay.
Questions people ask
What is the ongoing charge of 0H6M?
The ongoing charge of 0H6M is 0.50% a year — about £50 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of ALPS Medical Breakthroughs ETF 0.50% a year. Compared on 21/11/2026, 4 of the 29 other healthcare funds charge more, 1 the same and 24 less (share classes counted once).
What does 0H6M track?
0H6M tracks the S-Network Medical Breakthroughs Index.
Is 0H6M accumulating or distributing?
0H6M is distributing: income is paid out to holders as cash. It pays out once a year.
What is the ISIN of 0H6M?
The ISIN of 0H6M is US00162Q5936. An ISIN identifies one exact share class of a fund; 0H6M is its ticker on the London Stock Exchange.
How has 0H6M done after inflation?
Over the five years to 20/11/2026 0H6M’s total return was +28.5%, or +0.8% after UK CPIH inflation. Past performance is not a guide to future returns.
Similar funds
- XWHSXtrackers MSCI World Health Care UCITS ETF0.25% a year · £3.4bn
- IHCUiShares S&P 500 Health Care Sector UCITS ETF0.15% a year · £2.7bn
- DRDRiShares Healthcare Innovation UCITS ETF0.40% a year · £1.2bn
- XSHCXtrackers MSCI USA Health Care UCITS ETF0.12% a year · £1.2bn
- BTEKiShares NASDAQ US Biotechnology UCITS ETF0.35% a year · £994m
- CH5Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation0.30% a year · £847m
- ESIHiShares MSCI Europe Health Care Sector UCITS ETF Accum EUR0.18% a year · £792m
- 0DW6Amundi MSCI World Health Care UCITS ETF EUR ACC0.30% a year · £779m
Fund documents and methods
Methodology:ReturnsCategoriesAll methods
A machine-readable copy of this page: Markdown.